Exuberant fibroblast activity compromises lung function via ADAMTS4.
Exuberant fibroblast activity compromises lung function via ADAMTS4.
复制标题
DOI:
10.1038/s41586-020-2877-5
复制
发表时间:
2020-11
期刊:
影响因子:
64.8
通讯作者:
Thomas PG
中科院分区:
文献类型:
--
作者:
Boyd DF;Allen EK;Randolph AG;Guo XJ;Weng Y;Sanders CJ;Bajracharya R;Lee NK;Guy CS;Vogel P;Guan W;Li Y;Liu X;Novak T;Newhams MM;Fabrizio TP;Wohlgemuth N;Mourani PM;PALISI Pediatric Intensive Care Influenza (PICFLU) Investigators;Wight TN;Schultz-Cherry S;Cormier SA;Shaw-Saliba K;Pekosz A;Rothman RE;Chen KF;Yang Z;Webby RJ;Zhong N;Crawford JC;Thomas PG
Severe respiratory infections can result in acute respiratory distress syndrome (ARDS). There are no effective pharmacological therapeutics that have been shown to improve outcomes for patients with ARDS. Although the host inflammatory response limits spread of and eventually clears the pathogen, immunopathology is a major contributor to tissue damage and ARDS. In this study, we demonstrate that respiratory viral infection induces distinct fibroblast activation states, which we term extracellular matrix (ECM)-synthesizing, damage-responsive, and interferon-responsive. We provide evidence that the exuberant activity of damage-responsive lung fibroblasts drives lethal immunopathology during severe influenza virus infection. By producing ECM remodeling enzymes, in particular the ECM protease ADAMTS-4, and inflammatory cytokines, damage-responsive fibroblasts modify the lung microenvironment to promote robust immune cell infiltration at the expense of lung function. In three human cohorts, the levels of ADAMTS-4 in the lower respiratory tract were associated with the severity of seasonal and avian influenza virus infections. A therapeutic that targets the ECM protease activity of damage-responsive lung fibroblasts could provide a promising approach to preserving lung function and improving clinical outcomes following severe respiratory infections.
登录
查看更多内容
影响因子:
8.8
作者:
Hall MW;Geyer SM;Guo CY;Panoskaltsis-Mortari A;Jouvet P;Ferdinands J;Shay DK;Nateri J;Greathouse K;Sullivan R;Tran T;Keisling S;Randolph AG;Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network PICFlu Study Investigators
通讯作者:
Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network PICFlu Study Investigators
DOI:
10.1038/nri3665
发表时间:
2014-05
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
81.5
作者:
Matthay, Michael A.;Zemans, Rachel L.;Calfee, Carolyn S.
通讯作者:
Calfee, Carolyn S.
影响因子:
20.3
作者:
Hope, Chelsea;Foulcer, Simon;Asimakopoulos, Fotis
通讯作者:
Asimakopoulos, Fotis
影响因子:
12.3
作者:
Kelwick R;Desanlis I;Wheeler GN;Edwards DR
通讯作者:
Edwards DR